XML 29 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation
12 Months Ended
Jan. 31, 2021
Stock-Based Compensation
Note G: Stock-Based Compensation
Equity Award Programs
Our Amended and Restated 2001 Long-Term Incentive Plan (the “Plan”) provides for grants of incentive stock options, nonqualified stock options, stock-settled stock appreciation rights (collectively, “option awards”), restricted stock awards, restricted stock units (including those that are performance-based), deferred stock awards (collectively, “stock awards”) and dividend equivalents up to an aggregate of approximately 36,570,000 shares. As of January 31, 2021, there were approximately 2,475,000 shares available for future grant. Awards may be granted under the Plan to officers, employees and
non-employee
members of the Board of Directors of the
C
ompany (the “Board”) or any parent or subsidiary. Shares issued as a result of award exercises or releases are primarily funded with the issuance of new shares.
Stock Awards
Annual grants of stock awards are limited to 1,000,000 shares on a per person basis and have a maximum term of seven years. Stock awards granted to employees generally vest evenly over a period of four years for service-based awards. Certain performance-based awards, which have variable payout conditions based on predetermined financial targets, generally vest three years from the date of grant. Certain stock awards and other agreements contain vesting acceleration clauses resulting from events including, but not limited to, retirement, disability, death, merger or a similar corporate event. Stock awards granted to
non-employee
Board members generally vest in one year.
Non-employee
Board members automatically receive stock awards on the date of their initial election to the Board and annually thereafter on the date of the annual meeting of stockholders (so long as they continue to serve as a
non-employee
Board member).
Stock-Based Compensation Expense
During fiscal 2020, fiscal 2019 and fiscal 2018, we recognized total stock-based compensation expense, as a component of selling, general and administrative expenses, of $73,185,000, $64,163,000, and $59,802,000, respectively. As of January 31, 2021, there was $101,451,000 of unrecognized
stock-based compensation
 
expense
 
(net of estimated forfeitures), which we expect to recognize on a straight-line basis over a weighted average remaining service period of approximately
two years
. At each reporting period, all compensation expense attributable to vested awards has been fully recognized.
Restricted Stock Units
The following table summarizes our restricted stock unit activity during fiscal 2020:
 
      Shares    
Weighted Average
Grant Date Fair
Value
    
Weighted Average
Contractual Term
Remaining (Years)
    
Intrinsic
Value
1
 
Balance at February 2, 2020
     2,884,194     $                 54.09     
 
 
 
  
 
 
 
Granted
     1,145,610       51.67                    
Granted, with vesting subject to performance conditions
     267,000       93.17                    
Released
2
     (1,061,159     53.96                    
Cancelled
     (116,761     53.08     
 
 
 
  
 
 
 
Balance at January 31, 2021
     3,118,884     $ 56.62        3.05      $     402,087,000  
Vested plus expected to vest at January 31, 2021
     2,773,871     $ 56.61        3.42      $ 357,607,000  
 
1
 
Intrinsic value for outstanding and unvested restricted stock units is based on the market value of our common stock on the last business day of the fiscal year (or $128.92).
2
 
Excludes 170,308 incremental shares released due to achievement of performance conditions above target.
The following table summarizes additional information about restricted stock units:
 
     
Fiscal 2020
(52 weeks)
    
Fiscal 2019
(52 weeks)
    
Fiscal 2018
(53 weeks)
 
Weighted average grant date fair value per share of awards granted
   $ 59.51      $ 58.18      $ 49.57  
Intrinsic value of awards released
1
   $   74,853,000      $   65,403,000      $   34,213,000  
 
1
 
Intrinsic value for releases is based on the market value on the date of release.
Tax Benefit
We record excess tax benefits and deficiencies resulting from the settlement of stock-based awards as a benefit or expense within income taxes in the period in which they occur. During fiscal 2020, fiscal 2019, and fiscal 2018, the current tax benefit related to stock-based awards totaled $15,686,000, $13,793,000, and $9,927,000, respectively.